PMC:7795966 / 35315-35825 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1627","span":{"begin":230,"end":235},"obj":"Gene"},{"id":"1628","span":{"begin":105,"end":113},"obj":"Species"},{"id":"1629","span":{"begin":96,"end":104},"obj":"Disease"}],"attributes":[{"id":"A1627","pred":"tao:has_database_id","subj":"1627","obj":"Gene:3048"},{"id":"A1628","pred":"tao:has_database_id","subj":"1628","obj":"Tax:9606"},{"id":"A1629","pred":"tao:has_database_id","subj":"1629","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Figure 2 Visualization of (a) methemoglobin (MetHb) and (b) carboxyhemoglobin (COHb) values of COVID-19 patients reported in the literature. The green shaded areas refer to the reference ranges for healthy individuals in case of MetHb (0.67 ± 0.33% for healthy non-smokers [15]) and COHb (0.5–1.5% for healthy non-smokers [16]). Different subjects reported in the case reports are marked with “#”, and red lines with arrows indicate the development of subject-specific values during the course of the disease."}

{"project":"LitCovid-sentences","denotations":[{"id":"T260","span":{"begin":0,"end":141},"obj":"Sentence"},{"id":"T261","span":{"begin":142,"end":329},"obj":"Sentence"},{"id":"T262","span":{"begin":330,"end":510},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Figure 2 Visualization of (a) methemoglobin (MetHb) and (b) carboxyhemoglobin (COHb) values of COVID-19 patients reported in the literature. The green shaded areas refer to the reference ranges for healthy individuals in case of MetHb (0.67 ± 0.33% for healthy non-smokers [15]) and COHb (0.5–1.5% for healthy non-smokers [16]). Different subjects reported in the case reports are marked with “#”, and red lines with arrows indicate the development of subject-specific values during the course of the disease."}